Western Europe curbs GSK Consumer Healthcare

9 November 2018 - Deborah Wilkes

Premium

Worldwide sales at GlaxoSmithKline's Consumer Healthcare business increased by 3% at constant exchange rates in the third quarter of 2018, as sales declined in Europe but grew in the US and International markets.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: